Focus:

University of Colorado Cancer Center study shows healthy form of the leukemia-causing gene MLL may push pluripotent stem cells (which have proven difficult to use in human patients) to become durable hematopoietic stem cells (which are usable in patients, but have until now been impossible to make).

Channels: All Journal News, Blood, Cancer, Cell Biology, Stem Cells, Cancer Center Featured Story 2, Grant Funded News,

Keywords: Leukemia, Childhood Leukemia, MLL gene, Blood Stem Cells, Stem Cells, hematopoetic stem , pluripotent stem (iPS) cells , University Of Colorado Cancer Center, patricia ernst

Multiple studies out in Nature indicate that a patient's response to immune checkpoint blockade may depend on B cells located in special structures within the tumor.

Channels: Cancer, Healthcare, Immunology, Kidney Disease, Nature (journal), Cancer Center Featured Story 2, Embargoed Feed - hidden, All Journal News,

Keywords: Immunotherapy, Melanoma, Sarcoma, Kidney Cancer, B-cell, Renal Cell Carcinoma

Memorial Sloan Kettering Cancer Center has appointed Roxanne Taylor as Chief Marketing and Communications Officer, effective February 3. In this role, Ms. Taylor will be responsible for shaping and enhancing the MSK brand and will be accountable for building the long-term equity of the brand with all stakeholders.

Channels: Cancer Center Featured Story 2, Business Ethics, Cancer, Healthcare, In the Workplace, Marketing,

Keywords: Cancer, Communications, Marketing, Advertising, hospital leadership, leadership change, hospital comms, healthcare communication, healthcare comms, Memorial Sloan Kettering, cancer communications, Brand, Brand Management, healthcare brands

Ludwig Cancer Research is pleased to announce the appointment of Douglas Hanahan as a Distinguished Scholar at the Lausanne Branch of the Ludwig Institute for Cancer Research.

Channels: Cancer, Immunology, In the Workplace, Cancer Center Featured Story 2,

Keywords: Cancer, molecular biologist , Cancer Research

Dana-Farber Cancer Institute will establish the Riney Family Multiple Myeloma Initiative to help improve outcomes and accelerate understanding of the underlying biology for the most challenging types of myelomas, cancers that form in a type of white blood cell called a plasma cell.

Channels: Cancer, Family and Parenting, Healthcare, Grant Funded News, Cancer Center Featured Story 2,

Keywords: Myeloma, Multiple Myeloma, Dana Farber Cancer Institute, Dana Farber, Cancer

Tara Sanft, M.D., associate professor of Medicine (Medical Oncology) and Director of the Smilow Cancer Hospital (SCH) Survivorship Clinic, has been appointed the inaugural Chief Patient Experience Officer at Yale Cancer Center (YCC) and SCH at Yale New Haven Hospital.

Channels: Cancer, Healthcare, In the Workplace, Cancer Center Featured Story 2,

Keywords: Yale Cancer Center, Smilow Cancer Hospital, Cancer, Oncology, Dr. Tara Sanft

Sarah Mougalian, M.D., assistant professor of Medicine (Medical Oncology) has been named the inaugural Deputy Chief Ambulatory Officer at Smilow Cancer Hospital (SCH) at Yale New Haven Hospital.

Channels: Cancer, Healthcare, In the Workplace, Cancer Center Featured Story 2,

Keywords: Yale Cancer Center, YALE, Smilow Cancer Hospital, Oncology, Dr. Sarah Mougalian, Cancer

Very little information is known about the molecular development of leptomeningeal melanoma metastases (LMM), making it difficult to develop effective therapies. Researchers in Moffitt Cancer Center’s Donald A. Adam Melanoma and Skin Cancer Center of Excellence and the Department of Neuro-Oncology sought to change this by performing an extensive analysis of the molecular characteristics of the cerebrospinal fluid of patients with LMM. Their findings were published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

Channels: Cancer, Dermatology, Healthcare, National Institutes of Health (NIH), Cancer Center Featured Story 2, All Journal News,

Keywords: leptomeningeal melanoma metastases, LMM, Melanoma, Metastasis, Moffitt, Moffitt Cancer Center

Due in part to advanced surgical techniques, more effective medicines, and a multidisciplinary approach to treating the disease, University of Colorado Cancer Center is able to operate on 30+ percent of pancreatic cancer patients, nearly double the national average.

Channels: Cancer, Clinical Trials, Digestive Disorders, Healthcare, In the Workplace, Cancer Center Featured Story 2,

Keywords: University Of Colorado Cancer Center, Pancreas Cancer, Pancreatic Cancer, National Pancreas Foundation

Ludwig Cancer Research congratulates Ping-Chih Ho on his appointment as Associate Member at the Lausanne Branch of the Ludwig Institute for Cancer Research.

Channels: Cancer, Healthcare, In the Workplace, Cancer Center Featured Story 2,

Keywords: Cancer, Immunotheapy